|Front Page Previous Story Next Story|| BIO
President Feldbaum To Speak, Mar. 19 in Masur Auditorium
On Friday, Mar. 19, the National Cancer Institute will present a talk by Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), titled, "Biotechnology and NCI: Partners in Bringing Patients the Next Generation of Cancer Therapy." The talk will be held from 2 to 3 p.m. in Masur Auditorium, Bldg. 10, as part of the NCI Director's Seminar Series.
Feldbaum will provide an overview of the biotechnology industry, including its record of developing cancer therapies and also discuss the importance of collaboration between industry, NCI and academic centers. He is also expected to discuss such issues as conflict of interest and the taxpayer's fair rate of return on the investment in research.
As president of BIO, Feldbaum represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in the U.S. and 33 other countries. BIO members are involved in the research and development of health care, agricultural, industrial and environmental biotechnology products.
Feldbaum's lecture will be webcast at http://videocast.nih.gov. Sign language interpretation will be provided.
The next lecture in the NCI Director's Seminar Series, scheduled for Sept. 16, will feature Dr. Julie Gerberding, director of the Centers for Disease Control and Prevention, speaking from 1 to 2 p.m. in Masur Auditorium.
For more information, or for reasonable accommodation, contact Kate Haessler at (301) 348-1662 or the Federal Relay at 1-800-877-8339. More information about the series can be found at http://cancer.gov/directorscorner.
Up to Top